Allphase Clinical Research

DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in neurology/CNS (including spinal cord injury), oncology, ophthalmology, infectious disease/vaccines, and rare disease Phase I-IV clinical programs. DP Clinical provides a full complement of clinical trial services to pharmaceutical, biotech, and medical device companies including trial management, monitoring, data management, biostatistics, regulatory, safety monitoring and reporting, and medical writing. Since 1994, we have worked for clients of all sizes — small to large pharmaceutical and biotech companies, academic research institutions, and government sponsors.

DP Clinical provides integrated trial solutions as well as specific service components based on sponsor need. Our comprehensive services include:
• Project management
• Clinical trial monitoring
• Data management
• Biostatistics
• Pharmacovigilance and safety
• Regulatory affairs
• Quality assurance
• Medical writing

STATKING Clinical Services (SCS) is proud of its 30 year history of service to emerging pharmaceutical and medical device clients. Since the company's founding in 1989, the company has evolved from providing statistical consulting and data analysis services on a variety of household products to a full service Contract Research Organization (CRO) serving the pharmaceutical and medical device industries.

Today, the company employs a staff of product development specialists that are heavily involved in all phases of the Client's development program including protocol development, medical monitoring and clinical trial management. STATKING's highly experienced team of professionals has been instrumental in achieving regulatory approval for a number of new medical devices, drugs and biologics. At STATKING, our team is committed to providing services that meet or exceed all Federal Guidelines and Regulations for Good Clinical Practice.

Service Areas:
Protocol Development, Clinical Trial Management, Medical Monitoring, Clinical Study Monitoring, Medical Writing, Regulatory Submissions, Biostatistics, SAS Programming, Clinical Data Management and Safety Monitoring.

Therapeutic Areas:
Radiopharmaceuticals, Diagnostics, Oncology, CNS, Women's Health, GI, Orthopedic and Bone, Cardiac, Pain Management

NCGS, Incorporated is a full-service international CRO managing clinical trials since 1984 in drug, biologic, device, diagnostics and consumer products. NCGS provides full-service or strategic sourcing needs focused on risk mitigation. Contingency planning is actively employed, not just planned for. NCGS is a WBENC certified diversity supplier.

NCGS has supported the development or expanded labeling of 78 approved products and has ZERO 483s.
NCGS clinical teams are first in class, highly- tenured professionals
- 10+ years’ experience; A team remains throughout the trial
- Turnover rates are discernibly different at less than 3% annually

CLINICAL TRIAL THERAPEUTIC FOCUS INCLUDES:
- Neuro-Psych (CNS)
- Infectious Diseases / Critical Care
- Oncology, hematology, transplant
- Trials in multiple other areas have been conducted

ROBUST DIVISION OF COMPLIANCE & RECRUITMENT SPECIALIST
- CAPA initiatives
- Due diligence auditing
- eTMF
- Subject recruitment
- Call Center 24/7
- Trial Rescue
- Safety, SAE narratives and SAE reconciliation

FULL SERVICES INCLUDE:
• Clinical Operations and Monitoring
• Fully Integrated e-Based iCloud Systems
- e-REMOTE: Risk-based monitoring
- eTMF: TMF Migration, Consolidation
- ePAY: Grants, Contracts, Payments
- eDM: EDC, IWRS
- ePRO:Patient Reported Outcomes
- eCLIN: CTMS
• Medical Monitoring & Clinical Safety
• Quality Assurance & Regulatory Compliance
• Global Strategic Sourcing
• Medical Writing
• Biostatistics

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including the central nervous system, cardiovascular, metabolic, general medicine, oncology, and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit http://www.worldwide.com.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated."